TMPRSS2
Showing 26 - 50 of 124
Monoamine Oxidase Inhibitor on Phenotype of Blood Mononucleated
Recruiting
- SARS-CoV2 Infection
- blood sample
-
Le Kremlin-Bicêtre, FranceCHU Bicêtre
Dec 20, 2021
Covid19 Trial (Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone, The standard therapy)
Unknown status
- Covid19
- Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone
- The standard therapy
- (no location specified)
Nov 9, 2020
Intradermal Covid-19 Vaccine, Immungenicity and Safety, Immunocompromised Patients Trial in Hong Kong (ID BNT162b2 vaccine, IM
Recruiting
- Intradermal Covid-19 Vaccine
- +3 more
- ID BNT162b2 vaccine
- IM BNT162b2 vaccine
-
Hong Kong, Hong KongQueen Mary Hospital
Feb 19, 2023
COVID-19 Pneumonia Trial in Campinas, São Paulo (NestaCell®, Placebo)
Completed
- COVID-19 Pneumonia
- NestaCell®
- Placebo
-
Campinas, São Paulo, Brazil
- +3 more
Oct 26, 2022
COVID-19 Virus Infection Trial in Salvador (LCLT : 68% elemental L-carnitine and 32 % Tartric acid, Placebo)
Completed
- COVID-19 Virus Infection
- LCLT : 68% elemental L-carnitine and 32 % Tartric acid
- Placebo
-
Salvador, Bahia, BrazilSenai Cimatec
Jun 30, 2022
SLPI for Prostate Cancer
Recruiting
- Prostate Cancer
- Prostatic Neoplasm
- Secretory leukocyte protease inhibitor (SLPI) in prostate cancer
- +2 more
-
Florence, Tuscany, ItalyCareggi University Hospital
May 6, 2022
Past Coronavirus Disease 19 Infection on Live Birth Rates of
Not yet recruiting
- COVID-19
- Frozen Embryo Transfer
- frozen embryo transfer
-
Shanghai, ChinaShangHai JIAI Genetics&IVF Institute
Feb 21, 2023
Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study
Withdrawn
- COVID-19
- (no location specified)
Nov 1, 2022
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Melbourne (177Lu-PSMA)
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- 177Lu-PSMA
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Mar 28, 2022
SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill
Active, not recruiting
- COVID-19 Disease
- Data collection from lumbar puncture
- +3 more
-
Basel, SwitzerlandNeurosurgery, University Hospital Basel
Nov 1, 2021
Corona Virus Infection, SARS-CoV-2 Infection, SARS-CoV-2 PCR Test Positive Trial in Germany (biological, drug, other)
Completed
- Corona Virus Infection
- +3 more
- Convalescent plasma
- +3 more
-
Freiburg im Breisgau, Baden-Württemberg, Germany
- +5 more
Feb 9, 2022
Effect of Covid-19 Vaccination on Male
Not yet recruiting
- COVID-19 Pandemic
- semen analysis and hormonal proflie
- (no location specified)
Mar 29, 2022
Prostatic Adenocarcinoma and Its Clinicopathological Features
Not yet recruiting
- Prostate Adenocarcinoma
- Immunohistochemistry of prostate biopsy
- (no location specified)
Mar 30, 2021
COVID-19 Pneumonia Trial in Hong Kong (Bacillus subtilis)
Completed
- COVID-19 Pneumonia
- Bacillus subtilis
-
Hong Kong, Hong KongZentrogene Bioscience Laboratory Ltd
Dec 22, 2021
Epidemiologic, Clinical and Molecular Characteristics of Acute
Recruiting
- Covid19
- Patient with SAR-CoV-2 infection
-
Rozzano, Milan, ItalyHumanitas Research Hospital
Oct 17, 2022
Corona Virus Infection Trial in Denmark, Sweden (Camostat Mesilate, Placebo oral tablet)
Recruiting
- Corona Virus Infection
- Camostat Mesilate
- Placebo oral tablet
-
Hjørring, Region Nord, Denmark
- +10 more
Apr 27, 2021
Advanced Prostate Cancer Trial in Baltimore (Pelvic DCFPyL PET-MRI fusion or PET/MRI)
Recruiting
- Advanced Prostate Cancer
- Pelvic DCFPyL PET-MRI fusion or PET/MRI
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 22, 2022
COVID-19, Corona Virus Infection Trial in Sweden (Enzalutamide Pill)
Terminated
- COVID-19
- Corona Virus Infection
- Enzalutamide Pill
-
Malmö, Skåne, Sweden
- +5 more
May 30, 2022
Covid19, SARS-CoV Infection, Coronavirus Infection Trial in Baltimore (Camostat Mesilate, Bicalutamide 150 mg)
Terminated
- Covid19
- +2 more
- Camostat Mesilate
- Bicalutamide 150 mg
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 15, 2021
Prostate Cancer Trial in Vancouver, Toronto (Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab)
Recruiting
- Prostate Cancer
- Apalutamide 60mg Tab
- +5 more
-
Vancouver, British Columbia, Canada
- +1 more
May 25, 2022
Metastatic Castration-Resistant Prostatic Cancer Trial in Belgium, Sweden (Enzalutamide Oral Capsule [Xtandi], Abiraterone Oral
Recruiting
- Metastatic Castration-Resistant Prostatic Cancer
- Enzalutamide Oral Capsule [Xtandi]
- +6 more
-
Aalst, Belgium
- +22 more
Sep 28, 2021
Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)
Active, not recruiting
- Prostatic Neoplasms
- Low Grade Prostate Cancer
- Dietary intervention first
- Drug (Dutasteride) intervention first
-
Quebec, Canada
- +1 more
Mar 14, 2022
Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)
Recruiting
- Metastatic Hormone Naive Prostate Cancer
-
Sydney, New South Wales, Australia
- +4 more
Nov 4, 2022